
Corteva Inc (CTVA) Stock Forecast & Price Target
Corteva Inc (CTVA) Analyst Ratings
Bulls say
Corteva's management has expressed confidence in their guidance for 2025 and is comfortable with the current consensus estimates for 2026, indicating stability in their financial outlook. The projected revenues for the upcoming years are supportive of a strong financial performance, with expectations of approximately $3,845 million, slightly above the consensus of $3,823 million. Additionally, the sum-of-the-parts (SOTP) valuation suggests a modest upside of 12% over the next 12 months, with Corteva shares currently trading at 12.0 times the estimated enterprise value to EBITDA for 2025.
Bears say
Corteva's upcoming spin-off of its seeds business in late 2026 is anticipated to create a scenario described as "deal purgatory," which may hinder stock performance during this transition period. Additionally, management signals a reduction in expected growth and margins within the crop protection segment, which raises concerns about the company’s competitive positioning, particularly against established rivals like Bayer. Furthermore, potential risks such as fluctuating crop prices and advancements in precision application technologies could significantly impact industry dynamics and volumes, further contributing to a negative outlook on Corteva's stock.
This aggregate rating is based on analysts' research of Corteva Inc and is not a guaranteed prediction by Public.com or investment advice.
Corteva Inc (CTVA) Analyst Forecast & Price Prediction
Start investing in Corteva Inc (CTVA)
Order type
Buy in
Order amount
Est. shares
0 shares